Publications

Found 9 results
Author Title [ Type(Desc)] Year
Filters: Author is Zhang, Cenai  [Clear All Filters]
Journal Article
Parikh NS, Kamel H, Zhang C, Kumar S, Rosenblatt R, Spincemaille P, Gupta A, Cohen DE, de Leon MJ, Gottesman RF et al..  2022.  Association between liver fibrosis and incident dementia in the UK Biobank study.. Eur J Neurol.
Parikh NS, Kamel H, Zhang C, Gupta A, Cohen DE, de Leon MJ, Gottesman RF, Iadecola C.  2022.  Association of liver fibrosis with cognitive test performance and brain imaging parameters in the UK Biobank study.. Alzheimers Dement.
Magid-Bernstein JR, Li Y, Cho S-M, Piran PJ, Roh DJ, Gupta A, Shoamanesh A, Merkler A, Zhang C, Avadhani R et al..  2021.  Cerebral Microbleeds and Acute Hematoma Characteristics in the ATACH-2 and MISTIE III Trials.. Neurology.
Witsch J, Rutrick SB, Lansdale KN, Seitz A, Kamel H, Parikh NS, Segal AZ, Mir SA, Murthy SB, Niogi SN et al..  2023.  Influenza-Like Illness as a Short-Term Risk Factor for Arterial Dissection.. Stroke. 54(3):e66-e68.
Seitz A, Parauda SC, Omran SSalehi, Schweitzer AD, Liberman AL, Murthy SB, Merkler AE, Navi BB, Iadecola C, Kamel H et al..  2023.  Long-term risk of seizure after posterior reversible encephalopathy syndrome.. Ann Clin Transl Neurol.
Navi BB, Sherman CP, Genova R, Mathias R, Lansdale KN, LeMoss NM, Wolfe J, Skakodub A, Kamel H, Tagawa ST et al..  2021.  Mechanisms of Ischemic Stroke in Patients with Cancer: A Prospective Study.. Ann Neurol. 90(1):159-169.
Parauda SC, Zhang C, Omran SSalehi, Schweitzer AD, Murthy SB, Merkler AE, Navi BB, Iadecola C, Kamel H, Parikh NS.  2022.  Risk of Stroke After Posterior Reversible Encephalopathy Syndrome.. Stroke. :101161STROKEAHA122038673.
Merkler AE, Zhang C, D√≠az I, Stewart C, LeMoss NM, Mir S, Parikh N, Murthy S, Lin N, Gupta A et al..  2022.  Risk stratification models for stroke in patients hospitalized with COVID-19 infection.. J Stroke Cerebrovasc Dis. 31(8):106589.
Eruysal E, Ravdin L, Zhang C, Kamel H, Iadecola C, Ishii M.  2023.  Sexually Dimorphic Association of Circulating Plasminogen Activator Inhibitor-1 Levels and Body Mass Index with Cerebrospinal Fluid Biomarkers of Alzheimer's Pathology in Preclinical Alzheimer's Disease.. J Alzheimers Dis. 91(3):1073-1083.